Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
SteadyMed Ltd. (STDY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2018 GN SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results
07/31/2018 GN SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics
07/20/2018 GN HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd.
04/30/2018 GN United Therapeutics to Acquire SteadyMed Ltd.
03/30/2018 GN SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
12/08/2017 GN SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission
11/14/2017 GN SteadyMed Receives Favorable Ruling from U.S. Court of Appeals for the Federal Circuit
11/13/2017 GN SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update
10/12/2017 GN SteadyMed Receives Notice of Allowance for its European Patent Relating to Enhanced Reduction of Infusion-Site Pain
09/28/2017 GN SteadyMed Submits Type A Meeting Request Package to FDA
08/31/2017 GN SteadyMed Receives Refusal to File Letter from FDA for Trevyent® New Drug Application
08/11/2017 GN SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
08/09/2017 GN SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference
06/30/2017 GN SteadyMed Submits New Drug Application for Trevyent®
06/13/2017 GN SteadyMed to Present at the 2017 JMP Securities Life Sciences Conference
05/26/2017 GN SteadyMed Raises Additional Capital from Key Institutional Shareholder
05/12/2017 GN SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
05/12/2017 GN SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
05/02/2017 GN SteadyMed Receives USPTO Notice of Allowance for Patent Related to Key PatchPump® Technology
04/21/2017 GN SteadyMed Raises $30 Million in Private Placement
04/05/2017 GN SteadyMed Completes Clinical Validation Study of Trevyent®
03/31/2017 GN SteadyMed Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
03/29/2017 GN SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy